Two Seas Capital LP Portfolio Holdings

Two Seas Capital LP

  • $297 Million
  • Q3 2024

Two Seas Capital LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $297 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $112M, Arbutus Biopharma Corp with a value of $32.3M, Vistra Corp. with a value of $30M, Meta Platforms, Inc. with a value of $20.6M, and Immunovant, Inc. with a value of $18.6M.

Examining the 13F form we can see an increase of $47.2M in the current position value, from $250M to 297M.

Two Seas Capital LP is based out at Rye, NY

Below you can find more details about Two Seas Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $297 Million
Healthcare: $221 Million
Utilities: $36.5 Million
Communication Services: $27.2 Million
Technology: $6.5 Million
Financial Services: $5.79 Million
Industrials: $83,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$8.83B
$112 Million 37.75% of portfolio
9,724,893
Q3 2024 Reduced 5.76%
$519M
$32.3 Million 10.86% of portfolio
8,387,388
Q3 2024 Reduced 2.15%
$67.4B
$30 Million 10.07% of portfolio
252,666
Q3 2024 Reduced 19.55%
$1.27T
$20.6 Million 6.92% of portfolio
35,958
Q3 2024 Added 16.15%
$3.55B
$18.6 Million 6.26% of portfolio
676,614
Q3 2024 Reduced 2.28%
$11.5B
$11.8 Million 3.95% of portfolio
453,103
Q3 2024 New
$164M
$10.9 Million 3.65% of portfolio
6,584,278
Q3 2024 Added 14.8%
$3.63B
$6.68 Million 2.25% of portfolio
400,000
Q3 2024 Added 14.29%
$1T
$6.63 Million 2.23% of portfolio
40,000
Q3 2024 Reduced 18.98%
$82.1B
$6.5 Million 2.19% of portfolio
25,000
Q3 2024 New
$1.72B
$6.5 Million 2.19% of portfolio
528,928
Q3 2024 Reduced 24.86%
$610M
$2.9 Million 0.98% of portfolio
312,122
Q3 2024 Reduced 59.05%
$534M
$2.32 Million 0.78% of portfolio
275,000
Q3 2024 New
$871M
$2.02 Million 0.68% of portfolio
432,626
Q3 2024 Reduced 13.47%
$316M
$1.45 Million 0.49% of portfolio
412,414
Q3 2024 New
$7.41M
$83,000 0.03% of portfolio
100,000
Q3 2024 Reduced 91.31%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q3 2024 Added 6.55%
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 8.56%
Indivior PLC
-
$0 0.0% of portfolio
-
Q3 2024 Added 3.17%
Calumet Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q1 2024 New
Esperion Therapeutics Inc Ne
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 73.84%
Hut 8 Corp
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $297 Million
  • Prior Value $250 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email